# Creatine for Treatment of Depression Associated With Type 2 Diabetes

> **NCT03202095** · PHASE4 · WITHDRAWN · sponsor: **University of Utah**

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DRUG:** Creatine Monohydrate

## Key facts

- **NCT ID:** NCT03202095
- **Lead sponsor:** University of Utah
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2017-08-01
- **Primary completion:** 2024-06-10
- **Final completion:** 2024-06-10
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No referral from diabetes clinic.
- **Last updated:** 2024-06-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03202095

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03202095, "Creatine for Treatment of Depression Associated With Type 2 Diabetes". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03202095. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*